Management of COVID-19 Coagulopathy in a Patient with Severe Haemophilia A

A 54-year-old man with a long history of severe haemophilia A treated prophylactically with efmoroctocog alpha (3,000 IU twice weekly) was diagnosed with COVID-19 infection. He had multiple risk factors for COVID-19 severity including obesity, diabetes mellitus and hypertension. He required prolonge...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta Haematol
Hauptverfasser: Pinto Pereira, João, Hantson, Philippe, Gerard, Ludovic, Wittebole, Xavier, Laterre, Pierre-François, Lambert, Catherine, Hermans, Cédric
Format: Artigo
Sprache:Inglês
Veröffentlicht: S. Karger AG 2020
Schlagworte:
Case Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7573908/
https://ncbi.nlm.nih.gov/pubmed/32980842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510591
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge